Perks CM - Search Results

1

Editorial: The Role of the IGF/Insulin-IGFBP Axis in Normal Physiology and Disease.

Takahashi SI, Perks CM. Takahashi SI, et al. Among authors: perks cm. Front Endocrinol (Lausanne). 2022 Apr 21;13:892140. doi: 10.3389/fendo.2022.892140. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35528015 Free PMC article. No abstract available.

2

Localization of messenger ribonucleic acids for insulin-like growth factor I (IGF-I), IGF-II, and the type 1 IGF receptor in the ovine ovary throughout the estrous cycle.

Perks CM, Denning-Kendall PA, Gilmour RS, Wathes DC. Perks CM, et al. Endocrinology. 1995 Dec;136(12):5266-73. doi: 10.1210/endo.136.12.7588270. Endocrinology. 1995. PMID: 7588270

3

Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner.

Gill ZP, Perks CM, Newcomb PV, Holly JM. Gill ZP, et al. Among authors: perks cm. J Biol Chem. 1997 Oct 10;272(41):25602-7. doi: 10.1074/jbc.272.41.25602. J Biol Chem. 1997. PMID: 9325280 Free article.

4

The role of cell surface attachment and proteolysis in the insulin-like growth factor (IGF)-independent effects of IGF-binding protein-3 on apoptosis in breast epithelial cells.

Maile LA, Gill ZP, Perks CM, Holly JM. Maile LA, et al. Among authors: perks cm. Endocrinology. 1999 Sep;140(9):4040-5. doi: 10.1210/endo.140.9.6984. Endocrinology. 1999. PMID: 10465274

5

Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells.

Williams AC, Collard TJ, Perks CM, Newcomb P, Moorghen M, Holly JM, Paraskeva C. Williams AC, et al. Among authors: perks cm. Cancer Res. 2000 Jan 1;60(1):22-7. Cancer Res. 2000. PMID: 10646845

6

Overview of insulin-like growth factor physiology.

Holly JM, Perks CM, Stewart CE. Holly JM, et al. Among authors: perks cm. Growth Horm IGF Res. 2000 Apr;10 Suppl A:S8-9. doi: 10.1016/s1096-6374(00)90003-0. Growth Horm IGF Res. 2000. PMID: 10984272 Review. No abstract available.

7

Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes.

Burrows C, Holly JM, Laurence NJ, Vernon EG, Carter JV, Clark MA, McIntosh J, McCaig C, Winters ZE, Perks CM. Burrows C, et al. Among authors: perks cm. Endocrinology. 2006 Jul;147(7):3484-500. doi: 10.1210/en.2006-0005. Epub 2006 Apr 13. Endocrinology. 2006. PMID: 16614079

8

Insulin-like growth factor physiology: what we have learned from human studies.

Holly JM, Perks CM. Holly JM, et al. Among authors: perks cm. Endocrinol Metab Clin North Am. 2012 Jun;41(2):249-63, v. doi: 10.1016/j.ecl.2012.04.009. Epub 2012 May 8. Endocrinol Metab Clin North Am. 2012. PMID: 22682629 Review.

9

Role of the IGF axis in prostate cancer.

Biernacka KM, Perks CM, Holly JM. Biernacka KM, et al. Among authors: perks cm. Minerva Endocrinol. 2012 Jun;37(2):173-85. Minerva Endocrinol. 2012. PMID: 22691890 Review.

10

Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor.

Foulstone EJ, Zeng L, Perks CM, Holly JM. Foulstone EJ, et al. Among authors: perks cm. Endocrinology. 2013 May;154(5):1780-93. doi: 10.1210/en.2012-1970. Epub 2013 Mar 20. Endocrinology. 2013. PMID: 23515291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page